Overview

Safety and Tolerability of Oral Polyethylene Glycol (PEG 3350) Solution in Participants With Constipation (MK-8114-003)

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and tolerability of oral ingestion of PEG 3350 solution concentrate to oral ingestion of a placebo solution concentrate, in participants with constipation.
Phase:
Phase 2
Details
Lead Sponsor:
Bayer
Treatments:
Bisacodyl
Cathartics
Laxatives
Pharmaceutical Solutions
Polyethylene glycol 3350